Skip to main content

Peer Review reports

From: Pre- and intratherapeutic predictors of overall survival in patients with advanced metastasized castration-resistant prostate cancer receiving Lu-177-PSMA-617 radioligand therapy

Original Submission
31 Mar 2022 Submitted Original manuscript
23 Apr 2022 Reviewed Reviewer Report
8 May 2022 Reviewed Reviewer Report
12 May 2022 Reviewed Reviewer Report
24 May 2022 Author responded Author comments - Ulf Lützen
Resubmission - Version 2
24 May 2022 Submitted Manuscript version 2
29 May 2022 Author responded Author comments - Ulf Lützen
Resubmission - Version 3
29 May 2022 Submitted Manuscript version 3
13 Jun 2022 Reviewed Reviewer Report
14 Jun 2022 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
27 Jun 2022 Editorially accepted
4 Jul 2022 Article published 10.1186/s12894-022-01050-3

You can find further information about peer review here.

Back to article page